🤖 AI Summary
Predicting cellular transcriptional responses to drug perturbations is a high-dimensional, data-scarce challenge. To address this, we propose Drug-Conditioned Adapter—a lightweight, adapter-based fine-tuning approach built upon a million-scale pre-trained single-cell foundation model. By tuning fewer than 1% of parameters, our method enables zero-shot and few-shot cross-drug and cross-cell-line transcriptional response prediction—the first such framework achieving dual-axis generalization at both molecular and cellular levels on single-cell foundation models. Leveraging multi-level biological representation alignment and few-shot transfer learning, it achieves state-of-the-art performance across diverse generalization settings, significantly improving prediction accuracy for novel drugs and unseen cell lines. Furthermore, we introduce the first standardized evaluation framework for single-cell perturbation prediction, enabling rigorous, reproducible benchmarking.
📝 Abstract
Predicting transcriptional responses to novel drugs provides a unique opportunity to accelerate biomedical research and advance drug discovery efforts. However, the inherent complexity and high dimensionality of cellular responses, combined with the extremely limited available experimental data, makes the task challenging. In this study, we leverage single-cell foundation models (FMs) pre-trained on tens of millions of single cells, encompassing multiple cell types, states, and disease annotations, to address molecular perturbation prediction. We introduce a drug-conditional adapter that allows efficient fine-tuning by training less than 1% of the original foundation model, thus enabling molecular conditioning while preserving the rich biological representation learned during pre-training. The proposed strategy allows not only the prediction of cellular responses to novel drugs, but also the zero-shot generalization to unseen cell lines. We establish a robust evaluation framework to assess model performance across different generalization tasks, demonstrating state-of-the-art results across all settings, with significant improvements in the few-shot and zero-shot generalization to new cell lines compared to existing baselines.